Leading drug policy researchers reflect on the current evidence base, persistent gaps and priorities for future investigation, and policy responses amid rapidly evolving challenges.
The publication provides compelling evidence of the failures of punitive drug policies, but sorely lacks engagement with harm reduction, decriminalisation, responsible regulation and other evidence-based alternatives.
IDPC and civil society partners highlight the deep-rooted racial inequalities in drug law enforcement, urging for reforms to dismantle systemic harm and discrimination.
A new McGill University study finds that Toronto’s supervised drug consumption sites were not linked to rising crime — and in most cases, crime declined over time.
Evaluation of Switzerland’s cannabis pilot trials finds high participant satisfaction, no notable public-order incidents, and early signs that legal access models can reduce reliance on the illicit market.
Harm Reduction International discusses a 'global paradox' in which growing policy recognition and community resilience collide with devastating funding cuts that now threaten decades of harm reduction progress.
UNDP provides guidance to ensure that digital technologies for HIV and health are used ethically, protect human rights, and advance equity in the digital age.
Bewley-Taylor et al. find the GDPI useful for comparing international drug policy, and suggest improvements to better handle uncertainty and diverse data.